Amgen Inc. (NASDAQ:AMGN – Free Report) – Investment analysts at William Blair reduced their FY2025 ... and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women ...

William Blair downgraded Sprinklr (CXM) to Market Perform from Outperform without a price target after the company announced a 15% global workforce reduction. While expectations are low for the ...

In here, we explore the therapeutic landscape for rare diseases, analyzing drugs in development and those already approved by the European Medicines Agency (EMA). We differentiate between orphan drugs ...

The onset of the Covid-19 pandemic five years ago underscored the importance of diagnostic and vaccine developers to treat and prevent infectious diseases. Infectious disease is a theme for the ...

Fintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a Outperform recommendation. As of January 29, 2025, the average one-year ...

Kate Middleton Makes Last-Minute Appearance with Prince William at Poignant Event: 'It's Good to Be Able to Be Here' Arthur Edwards - WPA Pool/Getty During the emotional visit, William shared ...

Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of shareholders.

William H. Sanders has been named Rochester Institute of Technology’s 11th president. The current dean of Carnegie Mellon University’s College of Engineering was introduced to the RIT community on Jan ...

By utilizing advanced methodologies such as RNA sequencing and flow cytometry, we comprehensively analyzed the cellular and molecular landscape of liver diseases. These approaches enable uncovering ...